The New York Genome Center (NYGC) welcomes an exciting lineup of speakers in May for their Five Points Lectures, technically detailed weekly talks that bring scientists from New York and beyond to discuss their work, in depth, with researchers and clinicians from institutions city-wide.
On May 6th, Nicole Soranzo, from the UK’s Wellcome Trust Sanger Institute, joins NYGC to explain new ways to genomically probe complex diseases such as type-2 diabetes. On May 13th, the Jackson Laboratory’s Jacques Banchereau discusses how white blood cells’ genomes respond to vaccines, in learning to target potential foes. And on May 27th, Sarah Tishkoff, from the University of Pennsylvania’s Perelman School of Medicine, explores how people have genomically adapted to diverse climates, foods, pathogens, and other environmental factors across Africa.
About the Five Points Lectures
Named for a diverse early Manhattan neighborhood, the Five Points Lectures probe fresh research questions and methods, via lively interactive discussion. Lectures are held each Wednesday at 9 a.m., year-round, featuring speakers from the New York Genome Center’s member institutions and beyond.
About the New York Genome Center
The New York Genome Center (NYGC) is an independent, nonprofit at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations and partners are united in this unprecedented collaboration of technology, science, and medicine. We harness the power of innovation and discoveries to improve people’s lives — ethically, equitably, and urgently. Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, North Shore-LIJ, The Rockefeller University, Roswell Park Cancer Institute, Stony Brook University and IBM.
